These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

873 related items for PubMed ID: 15501954

  • 1. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
    Zhou X, Tan M, Stone Hawthorne V, Klos KS, Lan KH, Yang Y, Yang W, Smith TL, Shi D, Yu D.
    Clin Cancer Res; 2004 Oct 15; 10(20):6779-88. PubMed ID: 15501954
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.
    Korkolopoulou P, Levidou G, El-Habr EA, Piperi C, Adamopoulos C, Samaras V, Boviatsis E, Thymara I, Trigka EA, Sakellariou S, Kavantzas N, Patsouris E, Saetta AA.
    Histopathology; 2012 Aug 15; 61(2):293-305. PubMed ID: 22690797
    [Abstract] [Full Text] [Related]

  • 4. ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis.
    Tan M, Li P, Klos KS, Lu J, Lan KH, Nagata Y, Fang D, Jing T, Yu D.
    Cancer Res; 2005 Mar 01; 65(5):1858-67. PubMed ID: 15753384
    [Abstract] [Full Text] [Related]

  • 5. Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics.
    Dai B, Kong YY, Ye DW, Ma CG, Zhou X, Yao XD.
    BJU Int; 2009 Oct 01; 104(7):1009-16. PubMed ID: 19389013
    [Abstract] [Full Text] [Related]

  • 6. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
    Marzec M, Kasprzycka M, Liu X, El-Salem M, Halasa K, Raghunath PN, Bucki R, Wlodarski P, Wasik MA.
    Oncogene; 2007 Aug 16; 26(38):5606-14. PubMed ID: 17353907
    [Abstract] [Full Text] [Related]

  • 7. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P, Levidou G, Trigka EA, Prekete N, Karlou M, Thymara I, Sakellariou S, Fragkou P, Isaiadis D, Pavlopoulos P, Patsouris E, Saetta AA.
    BJU Int; 2012 Dec 16; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [Abstract] [Full Text] [Related]

  • 8. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
    Takano A, Usui I, Haruta T, Kawahara J, Uno T, Iwata M, Kobayashi M.
    Mol Cell Biol; 2001 Aug 16; 21(15):5050-62. PubMed ID: 11438661
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Determinants of rapamycin sensitivity in breast cancer cells.
    Noh WC, Mondesire WH, Peng J, Jian W, Zhang H, Dong J, Mills GB, Hung MC, Meric-Bernstam F.
    Clin Cancer Res; 2004 Feb 01; 10(3):1013-23. PubMed ID: 14871980
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease.
    Chen S, Nakahara T, Uchi H, Takeuchi S, Takahara M, Kido M, Dugu L, Tu Y, Moroi Y, Furue M.
    Br J Dermatol; 2009 Aug 01; 161(2):357-63. PubMed ID: 19438435
    [Abstract] [Full Text] [Related]

  • 13. Prognostic impact of the activation status of the Akt/mTOR pathway in synovial sarcoma.
    Setsu N, Kohashi K, Fushimi F, Endo M, Yamamoto H, Takahashi Y, Yamada Y, Ishii T, Yokoyama K, Iwamoto Y, Oda Y.
    Cancer; 2013 Oct 01; 119(19):3504-13. PubMed ID: 23861137
    [Abstract] [Full Text] [Related]

  • 14. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.
    Peponi E, Drakos E, Reyes G, Leventaki V, Rassidakis GZ, Medeiros LJ.
    Am J Pathol; 2006 Dec 01; 169(6):2171-80. PubMed ID: 17148679
    [Abstract] [Full Text] [Related]

  • 15. Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder.
    Sun CH, Chang YH, Pan CC.
    Histopathology; 2011 Jun 01; 58(7):1054-63. PubMed ID: 21707707
    [Abstract] [Full Text] [Related]

  • 16. Significance of 4E-binding protein 1 as a therapeutic target for invasive urothelial carcinoma of the bladder.
    Nishikawa M, Miyake H, Behnsawy HM, Fujisawa M.
    Urol Oncol; 2015 Apr 01; 33(4):166.e9-15. PubMed ID: 25618298
    [Abstract] [Full Text] [Related]

  • 17. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.
    Kim KK, Lee JJ, Yang Y, You KH, Lee JH.
    Carcinogenesis; 2008 Apr 01; 29(4):704-12. PubMed ID: 18258606
    [Abstract] [Full Text] [Related]

  • 18. Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas.
    Dobashi Y, Suzuki S, Kimura M, Matsubara H, Tsubochi H, Imoto I, Ooi A.
    Hum Pathol; 2011 Feb 01; 42(2):214-26. PubMed ID: 21040950
    [Abstract] [Full Text] [Related]

  • 19. Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR.
    Dutton A, Reynolds GM, Dawson CW, Young LS, Murray PG.
    J Pathol; 2005 Mar 01; 205(4):498-506. PubMed ID: 15714459
    [Abstract] [Full Text] [Related]

  • 20. Translation of the radioresistance kinase TLK1B is induced by gamma-irradiation through activation of mTOR and phosphorylation of 4E-BP1.
    Sunavala-Dossabhoy G, Fowler M, De Benedetti A.
    BMC Mol Biol; 2004 Apr 07; 5():1. PubMed ID: 15070431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.